Taiyen Biotech Co Ltd (1737) — Working Capital to Net Assets Ratio
Taiyen Biotech Co Ltd (1737) has a Working Capital to Net Assets ratio of 26.4% as of December 2025. Working capital of NT$1.80 Billion (current assets of NT$2.76 Billion minus current liabilities of NT$959.88 Million) is measured against net assets of NT$6.81 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 1737 equity to assets ratio to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Taiyen Biotech Co Ltd Working Capital to Net Assets (2009–2025)
This chart shows how Taiyen Biotech Co Ltd's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2009 to 2025. As of December 2025, the ratio stands at 26.4%, reflecting working capital of NT$1.80 Billion against net assets of NT$6.81 Billion TWD. Check Taiyen Biotech Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Taiyen Biotech Co Ltd (2009–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Taiyen Biotech Co Ltd from 2009 to 2025, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see 1737 market cap.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 26.4% | NT$1.80 Billion | NT$6.81 Billion | NT$2.76 Billion | NT$959.88 Million | ▼ -0.1 pp |
| 2024 | 26.4% | NT$1.76 Billion | NT$6.67 Billion | NT$2.93 Billion | NT$1.17 Billion | ▼ -3.0 pp |
| 2023 | 29.4% | NT$1.93 Billion | NT$6.55 Billion | NT$3.03 Billion | NT$1.10 Billion | ▼ -3.1 pp |
| 2022 | 32.5% | NT$2.17 Billion | NT$6.66 Billion | NT$3.09 Billion | NT$926.05 Million | ▲ +0.5 pp |
| 2021 | 32.1% | NT$2.09 Billion | NT$6.51 Billion | NT$3.39 Billion | NT$1.31 Billion | ▼ -2.6 pp |
| 2020 | 34.7% | NT$2.21 Billion | NT$6.36 Billion | NT$2.90 Billion | NT$694.88 Million | ▲ +2.7 pp |
| 2019 | 31.9% | NT$1.96 Billion | NT$6.15 Billion | NT$2.71 Billion | NT$744.60 Million | ▼ -4.4 pp |
| 2018 | 36.3% | NT$2.24 Billion | NT$6.16 Billion | NT$2.77 Billion | NT$535.14 Million | ▲ +0.8 pp |
| 2017 | 35.6% | NT$2.14 Billion | NT$6.02 Billion | NT$2.71 Billion | NT$572.02 Million | ▼ -2.3 pp |
| 2016 | 37.9% | NT$2.27 Billion | NT$5.99 Billion | NT$2.72 Billion | NT$450.48 Million | ▲ +5.2 pp |
| 2015 | 32.7% | NT$1.92 Billion | NT$5.86 Billion | NT$2.32 Billion | NT$403.64 Million | ▲ +2.1 pp |
| 2014 | 30.6% | NT$1.78 Billion | NT$5.82 Billion | NT$2.14 Billion | NT$354.44 Million | ▲ +1.3 pp |
| 2013 | 29.3% | NT$1.68 Billion | NT$5.73 Billion | NT$1.98 Billion | NT$300.29 Million | ▼ -7.2 pp |
| 2012 | 36.5% | NT$2.38 Billion | NT$6.53 Billion | NT$2.63 Billion | NT$245.32 Million | ▼ -2.7 pp |
| 2011 | 39.2% | NT$2.59 Billion | NT$6.61 Billion | NT$2.86 Billion | NT$266.35 Million | ▼ -0.8 pp |
| 2010 | 39.9% | NT$2.63 Billion | NT$6.58 Billion | NT$2.91 Billion | NT$284.31 Million | ▼ -0.7 pp |
| 2009 | 40.6% | NT$2.67 Billion | NT$6.57 Billion | NT$2.91 Billion | NT$242.97 Million | — |